Log in with your email address username.


[Editorial] False hope with the Right to Try Act

On Wednesday, May 30, US President Donald Trump signed the Right to Try Act, a law designed to remove the US Food and Drug Administration (FDA) from decisions on allowing patients to seek early access to experimental and unapproved drugs that have passed phase 1 trials. Advocates argue that streamlining the process will allow more people access, and perhaps allow lives to be extended or saved. Trump said that the new law could save “hundreds of thousands” of lives.